Among patients receiving dialysis for chronic kidney disease, high levels of alkaline phosphatase — a routinely measured laboratory marker of bone disease — may signal an increased risk of death, reports a new study.
Among patients receiving dialysis for chronic kidney disease, high levels of alkaline phosphatase — a routinely measured laboratory marker of bone disease — may signal an increased risk of death, reports a new study.